Letter to the Editor
Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma Sinclair et al,' describe a patient with a phaeochromocytoma who had normal levels of free urinary catecholamines in normo-as well as hypertensive episodes. In addition, a random sample of plasma showed normal noradrenaline and adrenaline levels. One explanation discussed by the authors is that the catecholamine output occurred in short-lived bursts. Detection in a 24 h collection then is difficult because of levelling out, and in a random plasma sample a short-living peak is easily missed.
In the introduction the authors comment that laboratory investigations are used to confirm the diagnosis of phaeochromocytoma. The investigations mentioned all have their drawbacks. Fortunately, our repertoire of biochemical tests is larger and probably better than that described. A very helpful aid to the diagnosis of phaeochromocytoma is the measurement of platelet catecholamines.s-' Platelets continuously take up and store circulating catecholamines. Thus, episodically elevated plasma catecholamine levels can result in increased platelet catecholamine concentrations. Indeed, elevated platelet noradrenaline levels have been found in phaeochromocytoma patients whose simultaneous plasma noradrenaline concentrations were within the normal range.'
The analysis of platelet catecholamines, once platelets are isolated, is as simple as the analysis of plasma catecholamines. However, the isolation of platelets requires differential centrifugation, preferably done within 75 min after sampling. This can be inconvenient in a clinical setting. In our laboratory we use serum in addition to plasma to screen patients for longer-term or episodically elevated circulating catecholamine levels. Serum
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Ann C/in Biochem 1992; 29: 358 provides information on both plasma and platelet noradrenaline content, probably as a result of the platelet release reaction during the clotting process when serum is prepared from blood. The noradrenaline content of platelets is approximately the difference of serum and plasma concentrations." Analysis of serum and plasma, easily prepared from one blood sample, provides us with information on transient as well as longterm circulating noradrenaline levels. We can thus increase the chances of detecting short-living bursts in catecholamine output.
I agree with Sinclair et al. that we cannot completely rely on biochemical methods to confirm the diagnosis of phaeochromocytoma. However, we should use tests that, to our knowledge, are the most sensitive. The analysis of platelets or serum plus plasma is a simple and inexpensive tool to reduce the amounts of 'false negative' results. Why not add it to our arsenal? C POPP-SNIJDERS Department of Endocrinology, Free University Hospital, De Boelelaan 11I7, 1081 HV Amsterdam, The Netherlands
